Monitors using near-infra red spectroscopy to assess cerebral oxygenation levels non-invasively in discrete areas of the brain have been used clinically for over 20 years. Interest has intensified recently, especially during cardiac surgery, and there are now five commercially available devices. Despite the attraction of being able to measure oxygen supply/demand in such a critical area, there has been only limited uptake of this technology in overall clinical anaesthetic practice. This narrative review aims to explore not only the rationale for using this technology but also the factors which have restricted its more widespread use.
Introduction
There has been an increasing emphasis on monitoring oxygen delivery (DO 2 ) during anaesthesia [1] , but global delivery does not assess the adequacy of DO 2 and oxygen supply/demand at the tissue level, especially in the brain [2, 3] . As this review will point out, assessment of regional cerebral oxygen saturation (rScO 2 ) could become a crucial part of a new 21st century multimodal monitoring approach to perioperative anaesthesia management [4] . Recent reviews have not only emphasised the importance of assessing and maintaining rScO 2 during major surgery, especially in the high-risk patient. For example, Murkin and Arango argue that 'the proper management of brain oxygenation should be one of the principal endpoints of all anaesthesia procedures' [5] , while Moerman and De Hert refer to the fact that it is rarely monitored: "especially, given its vital importance, the human brain is an alarming(ly) poorly monitored organ" [2] .
How well does cerebral oximetry fulfil this role? Is there a case to be made for it to become as essential an intra-operative monitor as pulse oximetry? A previous review suggested that, despite potential advantages of rScO 2 monitoring over other neuro monitoring techniques, further investigations and technological advances are necessary before its wider use in clinical practice [6] . Nevertheless, this review will attempt to answer some of the above questions and suggest a peri-operative role for this technology.
Background
Using photons emitted at a minimum of two wavelengths in the near-infrared (NIR) spectrum (700-1000 nm), the ratio or percentage of the oxygenated chromophore haemoglobin (HbO 2 ) at 920 nm to total Hb at 760 nm, expressed as rScO 2 can be estimated using a modification of the Beer-Lambert law and the principles of optical spectrometry. Although reflectance NIR spectroscopy techniques have been used for pulse oximetry, it is more usual in this application for the NIR photons to be transmitted through tissue (such as the finger or ear lobe) from emitter to detector. Clearly this is not possible in the brain due to the path length involved. However, Jobsis noted that photons in the NIR spectrum can at least easily penetrate the skin and skull and depending on the intensity of the emitter into the brain tissue itself [7] . Although some photons are dissipated in the cerebral tissues, others undertake a banana-shaped arc and reappear at the surface, the absorption of NIR light by the chromophores being proportional to their concentration. Thus, if a NIR detector is placed a few centimetres from the emitter, then the ratio HbO 2 /Hb and thus rScO 2 in cerebral tissues can be estimated.
Usually two detectors are used alongside the emitter, the proximal detecting photons reflected from superficial tissues and the distal one detecting those from deeper tissues, that is, brain at a depth of about 2-3 cm. A subtraction algorithm is then utilised to give a value for rScO 2 . If the optode containing the NIR emitter and detectors is placed on the forehead (often bilaterally) about 1.5-2 cm above the eyebrows, then the rScO 2 will be estimating cerebral oxygen supply/demand in the frontal cortex, an area of the brain which is most prone to hypoxaemia, the so-called 'watershed' area which is supplied by the anterior and middle cerebral arteries. It is important to note that there is no 'pulsatility' in the signal obtained (as with pulse oximeter plethysmography) so it is estimating cerebral tissue rScO 2 rather than the cerebral arterial blood oxygen saturation. With Hb predominantly in the venous compartment in the brain, a value of rScO 2 of around 70% is seen in normal volunteers [8] , but may change during hypoxia. Lower values are seen in the elderly and high-risk patients as will be seen later in this review. Since rScO 2 reflects the overall cerebral tissue oxygen supply/demand, if supply diminishes due to fall in oxygen delivery (DO 2 ) then the rScO 2 will fall. Similarly, it will fall if there is an increase in oxygen demand not matched by an increase in supply. In some elderly patients, a fall in arterial oxygen content (e.g. due to anaemia) may not be able to be compensated for by an increase in cerebral blood flow (CBF), and thus cerebral DO 2, hence rScO 2 will fall.
Some cerebral oximetry manufacturers claim superiority in that their monitor will measure 'absolute' vs. 'relative' values for rScO 2 . This is usually claimed due to the emitter having more wavelengths than the minimum two. However, the variation due to both the path length, scattering and penetration of the photons and confounders such as the thickness of the skull means that these claims are spurious [9] and the cerebral oximeter is thus more valuable as a 'trend' monitor. In addition, 'baseline' readings of rScO 2 in healthy volunteers may vary between 50% and 75% irrespective of whether one considers these values 'absolute', thus it is imperative to determine a baseline reading before elective surgery.
Although failure to monitor rScO 2 may seem surprising given that the technology behind its measurement is similar to that used for pulse oximetry (SpO 2 ), unlike a pulse oximeter, there are currently no Food and Drug Administration (FDA) standards in the USA for performance and accuracy. A study performed on five currently available oximeters according to these standards in volunteers subjected to hypoxia showed a pooled root mean square error of 8.06%, a value higher than for pulse oximeters, which is AE3% by FDA standards. Although responsive to desaturation, cerebral oximeters exhibited a large variation in reading errors between subjects, with mean bias possibly related to variations in the ratio of arterial and venous blood in the sampling area of the brain [9] .
What values are significant in indicating cerebral hypoxia?
What deviation from baseline is acceptable? Although 20% decline is usually considered significant [10] , it must be emphasised that due to the large inter individual differences in oximeter values this is not absolute [9] and in clinical practice steps should probably be taken to limit the decrease to a smaller decline, for example, 10% [11] . However, in order to maintain rScO 2 it is usually necessary to keep arterial oxygen content and DO 2 , mean arterial pressure (MAP), cardiac output (CO) and carbon dioxide (CO 2 ) tensions in the normal range.
A fuller description of the early history and technology behind NIRS and cerebral oximetry is contained in excellent reviews to which the reader is referred [5, 6, 12] .
Why measure rScO 2 ?
Over the last 20 years, peri-operative clinical haemodynamic management has moved successfully from simple maintenance of blood pressure to maintenance of flow, CO and thus on overall DO 2 [1] . However, this strategy ignores defects in oxygen supply/demand and organspecific autoregulation in individual organs, particularly the brain. Although the gut is probably the most sensitive organ to ischaemia, that is, damaged early by poor oxygen supply, it is difficult to monitor. The non-invasive nature of rScO 2 has revealed hypoxic changes in the elderly brain occurring in the absence of major haemodynamic changes elsewhere, often due to blood loss and haemodilution [13] .This has led to the proposition that the brain may be considered an 'index organ', in which it is feasible to monitor tissue oxygenation non-invasively, and thus may act as an early warning system to indicate potential deficits in overall DO 2 which may lead to postoperative complications [14] .
Other techniques for monitoring global rather than local or regional (as with rScO 2 ) brain oxygenation such as intravascular catheters to assess jugular venous oxygen saturation (SjVO 2 ) are considered too invasive for routine use outside cardiac surgery. Although only a small volume of prefrontal cortex tissue (1 ml) is monitored if correct forehead placement is used, this tissue is in the 'watershed' area of the brain as mentioned above. Significant desaturations may occur here in the absence of global supply/demand changes (e.g. as assessed by SjVO 2 ). In volunteers subjected to global hypoxia by breathing a hypoxic mixture, there was a reasonable correlation between SjVO 2 and rScO 2 [9] . However, one can find a reduction in rScO 2 even when SjVO 2 is in the normal range.
Adoption of new technology in anaesthetic practice has been very patchy and slow. Following the clinical introduction and availability of pulse oximetry in 1984 it was not until much later that it became a de facto standard for monitoring in all developed and most developing countries. Since the first clinical anaesthesia papers suggesting benefit of measuring rScO 2 appeared more than 20 years ago [15] , it is surprising that the monitor has not been used more widely. Apart from the technical reasons mentioned above, the lack of a dominant technology (there are five different oximeters in the market in the UK) and high cost of disposables (around £50-100 per electrode) it is probably the lack of demonstrated outcome benefit that has limited its use.
However, in proposing the cerebral oximeter as 'the standard monitor of the future' Moerman and de Hert [2] point out that pulse oximetry has never shown any outcome benefit [17] but few people would suggest abandoning its use.
There have been many comprehensive recent systematic and narrative reviews on the role and application of cerebral oximetry covering the mode of operation [6] , confounders and general application [5, 6, [19] [20] [21] , looking specifically at patients undergoing cardiovascular surgery [22] [23] [24] general adult and paediatric patients, but excluding cardiac and thoracic surgery [2] , a systematic review of cerebral oximetry in non-cardiac surgery [25] , thoracic surgery [26] and reviews looking at overall tissue oxygenation as well as cerebral oxygenation [27] .The reader is referred to these excellent reviews for further information and they are summarised in the Table 1 .
Non-cardiac adult surgery indications for rScO 2 monitoring
A recent systematic review of the use of NIRS in noncardiac surgery in adults concluded that many routine surgical procedures are associated with falls in rScO 2 and this might be associated with the occurrence of post operative cognitive decline (POCD) [25] . It is important to note that the effects of both the depth and duration of rScO 2 desaturations need to be assessed, for example, the 'area under the curve, AUC' and not just 'one-off' values. There are specific surgical areas such as beach chair (e.g. shoulder surgery), carotid artery endarterectomy and general surgery in the elderly and in high-risk patients, where rScO 2 monitoring has been widely used. In addition, other areas such as use of rScO 2 in managing cardiac arrest and resuscitation will be briefly considered.
Catastrophic ischaemic brain damage has been reported in healthy patients undergoing shoulder surgery in the beach chair position (BCP) [28, 29] . Unrecognised cerebral hypoperfusion may have occurred, indicating that routine anaesthesia monitoring may not suffice [30] . Simply trying to maintain mean arterial pressure (MAP) in the upright position may not be sufficient as agents such as phenylephrine when used in relatively high doses to treat low MAP may actually decrease cardiac output (CO) and thus rScO 2 [31] .
Several studies have shown significant falls in rScO 2 when the BCP is used [30, 32] , whereas others have not [33] . This controversy led the Anesthesia Patient Safety Foundation (APSF) in USA to initiate the APSF beach chair study [34] . This compared rScO 2 in 109 patients in the BCP vs. 109 in the lateral decubitus position (LDP). However, due to surgical considerations the patients were not randomised to LDP or BCP. Using a continuous moving Pearson correlation coefficient between MAP and rScO 2 to calculate the COx index [35] , they attempted to see whether cerebral autoregulation was impaired in the BCP vs. the LDP. The COx has been used by the same group in cardiac surgery to predict the limits of cerebral autoregulation (see later); COx approaches 0 (usually < 0.3) when on the flat part of the MAP autoregulation curve (see below). As MAP falls, COx approaches 1 suggesting that cerebral perfusion is now directly related to MAP and the limits of autoregulation have been reached. Although they found lower rScO 2 in the BCP, as with other studies, this was not associated with a worsened outcome. In summary, BCP may occasionally result in cerebral hypoxaemia but since the incidence is incredibly low it would be difficult to justify routinely monitoring rScO 2 in these patients.
Measurement of cerebral oxygenation during carotid endarterectomy (CEA) would appear to be a major indication for this technology as hypoxaemic stroke is an important contributor to postoperative morbidity and mortality [36] . However, its application in this surgery and its possible benefits are disputed.
Cerebral oximetry was first evaluated in a small 1995 study of 22 patients undergoing CEA under general anaesthesia (GA) [15] . Accuracy or applicability of the technology in studies assessing rScO 2 in CEA patients under GA is questionable as rScO 2 can only be compared with other surrogates of poor cerebral perfusion such as EEG change, transcranial Doppler (TCD) or measurement of stump pressure after clamping. However, ipsilateral falls in rScO 2 did seem to reflect effects of carotid clamping in some patients. Can rScO 2 desaturation following clamping predict the need for shunt placement?
There has been a move towards performing CEA under local anaesthesia (LA) with 'awake testing' and a deterioration in conscious state (DICS) following clamping as the 'gold standard' indication for shunt replacement. However, the results of the GALA trial (GA vs. LA for CEA) did not suggest any outcome benefit of LA and thus many units still conduct CEA under GA [36, 37] .
Two issues arise. Can rScO 2 decline be used as an indication for shunt insertion of CEA under GA and if CEA is performed under LA with 'awake testing', is rScO 2 monitoring superfluous?
Although rScO 2 has been compared with other modalities, such as shunt pressure, transcranial Doppler and EEG, in CEA under GA all these techniques are surrogates and thus are not easily comparable. One way is to compare rScO 2 changes with 'awake testing' and DICS in CEA under LA to try and determine a precise cut-off value in rScO 2 decline which predicts DICS. If achieved, this percentage decline could then be used to indicate the need for shunt replacement in CEA under GA. A study using the Invos 3100 cerebral oximeter (the first to be clinically available, Invos, Medtronic USA) to calculate rScO 2 in awake patients undergoing CEA found an association between falls in rScO 2 and deterioration in conscious state (DICS). The best cut-off point seemed to be a 20% decline in rScO 2 following clamping. However, the positive predictive value (i.e. the percentage of patients who actually had DICS) was only 33.3%. The negative predictive value, however, was very high at 97.4% which suggested that only 2.6% of patients will experience a DICS if the fall of rScO 2 is limited to less than 20% [38] . In a study comparing awake testing vs. rScO 2, good correlation was found and no patient experienced a DICS unless the rScO 2 fell by more than 19% [39] . Another study in a similar group of 100 patients where awake testing and DICS was used to determine the need for a shunt, of nine patients who had a fall in rScO 2 of greater than 22% only three required a shunt [40] .
In our experience [39] , a fall in rScO 2 may precede DICS and requirement for a shunt by many minutes. Thus, rScO 2 decline gives warning of potential DICS and may be reversible by raising MAP and CO [39] and by increasing inspired oxygen concentration [41] . In such cases, a shunt may be avoided. If one is using GA for CEA then maintenance of rScO 2 during clamping might avoid a shunt in some patients, itself a potential cause of stroke.
However, it is likely that due to the low positive predictive value [38, 40] some patients under GA will receive a shunt unnecessarily when rScO 2 falls by around 15-20%. Thus, many centres use rScO 2 monitoring to guide cardiovascular management of the patient to maintain rScO 2 rather than as a direct indication for shunt placement [39, 42] .
As a result of these controversies, cerebral oximetry is still not established as an essential monitor for CEA.
Cerebral desaturation is common in elderly patients undergoing major surgery especially if associated with blood loss [13] . The only large RCT of the use of cerebral oximetry in 122 elderly general surgical patients was published in 2005 [10] . All patients had rScO 2 monitoring but the values were hidden from the control group patients (66) . In the intervention group, rScO 2 was maintained at least 75% of baseline value using a two-stage intervention process:
Stage 1: maintaining neutral head position, increasing FIO2, raising end-tidal carbon dioxide (EtCO 2 ) to at least 35 mm, and giving vasoconstrictors and fluids to maintain systolic blood pressure > 90 mmHg.
If stage 1 is not effective then progress to stage 2: Stage 2: giving propofol (0.5 mg.kg
À1
) or increasing sevoflurane concentration to reduce brain oxygen consumption.
Postoperative cognitive decline (POCD) was assessed simply by the mini-mental state examination (MMSE) 1 day before surgery and at 1 week postsurgery. Patients who desaturated (mainly in the control group) had an increase in POCD and hospital length of stay. However, overall there was no difference in outcome. Clearly, this study needs to be repeated in a larger group of patients but using a more sensitive measure of POCD rather than MMSE [43] and using depth of anaesthesia monitoring to avoid excessively deep an anesthesia which may itself contribute to POCD [44, 45] .
In a RCT of 72 patients using both maintenance of rScO 2 > 15% of baseline and depth of anaesthesia using BIS (Medtronic, USA) in the 40-60 range in the intervention group reduced the level of POCD as assessed by a computerised test battery [11] .
Following the introduction of cerebral oximetry monitoring, various case reports emerged demonstrating the ability of rScO 2 to track changes in cardiac output during resuscitation [46] . Studies in emergency department patients in cardiac arrest indicated that higher rScO 2 on admission [47] and during CPR is associated with better outcome [47] and higher rates of return of spontaneous circulation [48] . In a large multicentre study between the USA and UK it was again noted that return of spontaneous circulation was associated with higher cerebral oxygenation levels and time with rScO 2 greater than 50% during CPR best predicted cerebral performance category of the 7% of patients who achieved this at discharge [49] . However, other studies have not shown this predictability [50] . A recent meta-analysis [51] and systematic review [52] assessing rScO 2 monitoring during resuscitation from cardiac arrest suggests a role in management of these patients and that higher initial rScO 2 values correlate with greater chances of return of spontaneous circulation.
Cerebral oximetry in cardiac surgery
The 5th National Audit Project (NAP5) of the Royal College of Anaesthetists and Association of Anaesthetists of Great Britain and Ireland in the UK reported that 40,600 patients had cardiac surgery annually [53] . Patients undergoing cardiac surgery have become older, and they have more pre-operative risk factors with a mean EuroSCORE of 7.7 in 2013, which is about 25% higher than 10 years ago. Nevertheless, the 30-day in-hospital mortality has decreased over the last 10 years from 3.7 in 2003 to 2.7 in 2013. This is probably due to better and improved peri-operative care, including improved techniques and technical advances used by perioperative teams. Nevertheless, postoperative morbidity is still high with incidences of postoperative delirium of up to 48% [54] , acute kidney injury of about 38% [55] and myocardial infarction up to 24% [55] , resulting in a 1-year mortality of about 5% after bypass surgery [55] .
With such a high rate of reported end-organ injury, the question remains whether improved optimisation of DO 2 in order to provide enough oxygen at tissue levels can be achieved. Cerebral oximetry assesses relative trends of cerebral tissue oxygenation and thus has the potential to monitor a mismatch of oxygen supply and demand in the brain [9] . In addition, continuous rScO 2 monitoring was shown to be useful in assessing cerebral autoregulation during cardiac surgery non-invasively [35] .
Over the last 10 years, the important clinical question whether we can improve postoperative outcomes in cardiac surgery if we respond to and treat cerebral desaturations has been investigated extensively with so far inconclusive results.
Significant intra-operative decreases of rScO 2 in cardiac surgery have been shown to be associated with stroke [56] , postoperative cognitive decline [57, 59] , delirium [60] , longer ICU and hospital stay [61] , and an increase in overall major organ dysfunction and mortality [61] . In addition, a prospective observational study in 1178 patients suggested that absolute low preoperative readings before cardiac surgery indicate significantly increased postoperative morbidity and mortality in high-risk patients [62] . In order to treat rScO 2 desaturations, strategies and algorithms have been developed, with the intention to improve postoperative outcomes. These have been described in detail [63] and have been shown to be effective [64] . They include increasing the pump flow, raising mean arterial pressures, normalisation of arterial CO 2 pressures, deepening of anaesthesia, increasing inspiratory oxygen concentrations and also blood transfusion.
It has been recognised that rScO 2 desaturations identify malpositions of cardiopulmonary bypass cannulae, especially during aortic surgery, which can easily be reversed. This manoeuvre can prevent major hypoperfusion of vital organs and thus postoperative complications in these rare events. However, there is only low-level evidence that intraoperative rScO 2 monitoring and treatment of episodes of low rScO 2 reduces postoperative neurological complications.
Clinical trials investigating intra-operative treatments of rScO 2 desaturations include two randomised trials. The first investigated 200 patients undergoing coronary artery bypass graft (CABG) operations resulted in less prolonged cerebral desaturations and shorter stays in ICU but no difference in overall complications. However, more patients in the untreated control group had major organ morbidity and mortality [61] . The second investigated 240 patients undergoing CABG surgery, with the treatment group receiving intra-operative interventions in order to improve rScO 2 desaturations. Interestingly, there was no difference in POCD between the two study groups, suggesting that the interventions (see above) were not effective. All interventions were performed in the operating room only. However, patients with cerebral desaturations (irrespective of the intervention) had a higher risk of early postoperative cognitive dysfunction [58] .
Following these two inconclusive trials, especially with regard to the effectiveness of the intervention, two recent multicentre RCTs investigated whether rScO 2 desaturations can be treated successfully by suggested algorithms and interventions. Both trials demonstrated that in almost all patients (95-97%) rScO 2 desaturations were treated successfully in the intervention groups [64, 65] .
Dechamps et al. investigated 201 patients, with desaturations defined as an rScO 2 below 10% of the baseline [64] . Subramanian et al. investigated 235 adult patients, with 50-75% patients presenting with one or more desaturations, which were defined as a decline of > 20% [65] . The percentage of patients receiving individual interventions included treating hypotension in 29.8% of patients, increased inspiratory oxygen concentration in 15.6%, normalisation of cardiopulmonary bypass flow in 14.2%, red blood cell transfusion in 13.8%, decreasing cardiopulmonary bypass 'sweep speed', that is, retaining CO 2 in the blood in 11.1%, deepening of anaesthesia in 10.7%, adjusting of cardiopulmonary bypass cannulae in 8.0%, repositioning of the head to midline in 2.7% of patients [65] . This list demonstrates impressively that 10% of all patients received at least one intervention.
In summary, in cardiac surgery, peri-operative prolonged rScO 2 desaturations have been shown to be strong prognostic indicators of poor clinical outcome. Two well-powered recent multicentre studies mentioned above demonstrated that treatment algorithms can normalise rScO 2 saturations successfully in 95-97% of patients.
Future trials will now need to address whether these treatment algorithms will not only prevent rScO 2 desaturations but also improve postoperative outcomes in cardiac surgery. Since significant cerebral desaturation events continue to occur into the early postoperative period [66] , monitoring and interventions will need to be continued for several hours post surgery. Indirectly, the potential of improving clinical outcomes with improvement of cerebral rScO 2 in cardiac surgery has been shown, however, direct evidence might still be necessary.
Conclusions
There is probably a long way to go before cerebral oximetry can be regarded as standard monitoring, even in some of the specialised surgical procedures referred to in this article; for example, it does not even feature in national monitoring guidelines [67] . Cerebral oximetry is not yet a perfect technology when used to measure absolute cerebral tissue oxygen saturation levels, however, it probably does assess rScO 2 trends and desaturations caused by a mismatch of oxygen supply/demand in the brain. Many proof-of-concept trials assessing continuous rScO 2 measurements in cardiovascular surgery and in the elderly undergoing general surgery have demonstrated that continuous peri-operative rScO 2 monitoring has the potential to improve postoperative outcomes. Future trials will now determine whether improved outcomes with rScO 2 monitoring in combination with treatment of rScO 2 desaturations in cardiovascular surgery and in the elderly are seen in larger clinical settings and populations.
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